Alain Micaleff
Merck Serono (Switzerland)(CH)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Meta-analysis and systematic reviews, Pharmaceutical Economics and Policy, Statistical Methods in Clinical Trials, Health Policy Implementation Science
Most-Cited Works
- → Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.(1992)189 cited
- → Balancing benefit and risk of medicines: a systematic review and classification of available methodologies(2014)118 cited
- → Hepatic Reactions During Treatment of Multiple Sclerosis with Interferon-??-1a(2003)96 cited
- → Recommendations for benefit–risk assessment methodologies and visual representations(2016)67 cited
- → Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions(2015)45 cited
- → Literature review of visual representation of the results of benefit–risk assessments of medicinal products(2015)33 cited
- → Benefit–risk assessment in a post‐market setting: a case study integrating real‐life experience into benefit–risk methodology(2014)21 cited
- IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines(2014)
- → Weighing benefit–risk of medicines: concepts and approaches(2011)9 cited
- → Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study(2016)8 cited